PerkinElmer is complementing its full range of effective prenatal screening assays by providing new assays for pre-eclampsia risk assessment. Pre-eclampsia is one of the most common of the serious complications of pregnancy. It affects the mother, the unborn baby and the neonate. Early identification of women at high risk for pre-eclampsia is an important step towards improving the outcome of pregnancies and preventing pre-eclampsia.
Towards screening for early-onset pre-eclampsia
Our intense research activities in the collaboration with leading experts has led to identification of biomarkers that may facilitate a more effective method of screening for pre-eclampsia, when combined with established risk factors and biophysical markers. PerkinElmer has launched the first placental growth factor (PlGF) assay* to be used as an aid in screening pregnant women for early-onset pre-eclampsia.
Healthy pregnancies right from the start
At PerkinElmer, our vision is of healthy pregnancies right from the start. We are recognized for our strong commitment to maternal health and we already are a global leader in prenatal screening.
* PerkinElmer PlGF kits are not available in the US, Canada and some other countries. For information on availability please contact your local sales representative.